Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-08-08
1999-09-21
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530331, 562445, A61K 3805
Patent
active
059554355
ABSTRACT:
Peptidyl compounds have therapeutic utility via MMP and TNF inhibitory activity.
REFERENCES:
Holmquist, B., B.L. Vallee (1980) Metal-coordinating substrate analogs as inhibitors of metalloenzymes. Chemical Abstracts 92: abstract No. 89874h.
Mori, T. et al. (1979) Comparative studies on protective effect of various sulfhydryl compounds against cell death and DNA strand breaks induced by x-rays in cultured mouse L cells. Chemical Abstracts 91: abstract No. 32686y.
Isomura, Y. et al. (1992) Preparation of amide derivatives as collagenase inhibitors. Chemical Abstracts 117: abstract No. 212156q.
Corey, E.J., S. Hashimoto (1981) A practical process for large-scale synthesis of (S)-5-hydroxy-6-trans-8,11,14-cis-eicosatetraenoic acid (5-HETE). Chemical Abstracts 95: abstract No. 24207k.
Baxter Andrew Douglas
Montana John Gary
Darwin Discovery Limited
Lukton David
Tsang Cecilia J.
LandOfFree
Peptidyl compounds having MMP and TNF inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidyl compounds having MMP and TNF inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidyl compounds having MMP and TNF inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80287